This issue brief highlights a number of Medicaid prescription drug issues that remain for states after the movement of dual eligibles into the Medicare Part D drug benefit. The brief describes new data, prepared by Mathematica and available on the 39;47 website, that provide detailed information...

Before Medicare Part D, Congress authorized the Medicare disease management demonstration to evaluate whether disease management programs—in conjunction with a comprehensive prescription drug benefit—could improve health outcomes and reduce Medicare expenditures. The demonstration...

The Medicaid Value Program tested interventions to improve care for adult Medicare beneficiaries with multiple chronic conditions. This report presents findings from Mathematica's evaluation; estimates of program effects, produced by the programs themselves; and case studies for the 10...

This articles examines interim impacts of a disease management demonstration for Medicare fee-for-service beneficiaries also enrolled in Medicaid (dual eligibles). The study randomly assigned dual eligibles with congestive heart failure, coronary artery disease, and/or diabetes to treatment or...

Multidisciplinary, multi-institutional collaboration has become a key feature of comparative effectiveness research (CER), and CER funders have made promotion of these types of collaboration an implicit, and sometimes explicit, goal of funding. An important challenge in evaluating CER programs...

As part of the evaluation of the American Recovery and Reinvestment Act (ARRA) investment in comparative effectiveness research (CER), Mathematica developed a conceptual framework to guide future efforts to assess the impact of CER. In addition, we explored methodological challenges related to...

This article describes American Reinvestment and Recovery Act comparative effectiveness research (CER) data infrastructure (DI) investments and identifies facilitators and barriers to implementation. We reviewed original project proposals, conducted an investigator survey, and interviewed...

To improve health outcomes, clinicians and patients must have evidence-based information available to help them make informed decisions, the knowledge and skills to use this information, and positive attitudes about the value of using comparative effectiveness research (CER) in decision making....

The study examined public attitudes toward and understanding of comparative effective research (CER). Six focus groups were conducted with consumers in three major cities to examine the extent of familiarity and understanding of CER.